Data as of Dec 19
| +0.18 / +0.19%|
The 23 analysts offering 12-month price forecasts for CVS Caremark have a median target of 103.00, with a high estimate of 110.00 and a low estimate of 75.00. The median estimate represents a +7.63% increase from the last price of 95.70.
The current consensus among 27 polled investment analysts is to Buy stock in CVS Caremark. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.